mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.0008 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0009 |